# FDA Inspection 1284308 - ABRYL LABORATORIES PRIVATE LIMITED - September 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/abryl-laboratories-private-limited/336bb1f1-2ac6-49be-af9f-8536f3d40559
Source feed: FDA_Inspections

> FDA Inspection 1284308 for ABRYL LABORATORIES PRIVATE LIMITED on September 26, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284308
- Company Name: ABRYL LABORATORIES PRIVATE LIMITED
- Inspection Date: 2025-09-26
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1284308 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/abryl-laboratories-private-limited/fcfba730-196f-4125-a27d-79797e789785)
- [FDA Inspection 1248254 - 2024-08-20](https://www.keypedia.com/records/fda_inspections/abryl-laboratories-private-limited/98e2cd47-bfae-4821-ba05-b1d467e24ef4)
- [FDA Inspection 1223096 - 2023-11-20](https://www.keypedia.com/records/fda_inspections/abryl-laboratories-private-limited/5de8b39e-0474-475d-ae0a-0ef4ca6d5993)

Company: https://www.keypedia.com/companies/abryl-laboratories-private-limited/2c82dd5b-3db2-4630-9c9c-45113aa3d31f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c